CNS Drug Delivery: Prodrug Approaches

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson
Download our mobile app to listen on the go
Get App

Questions and Answers

What is one of the major difficulties in the development of drugs for the CNS?

  • Crossing the blood-brain barrier (BBB) (correct)
  • Active efflux from the brain into the blood
  • Passive diffusion
  • Reaching peripheral immune cells

Which prodrug strategy involves increasing carrier-mediated or receptor mediated transport through the BBB?

  • Decreasing the active efflux of the drug from the brain into the blood
  • Increasing passive diffusion by masking polar groups on the parent drug
  • Increasing carrier-mediated or receptor mediated transport through the BBB (correct)
  • Decreasing the process of prodrug biotransformation in peripheral tissues

Why is it essential for prodrug biotransformation to be slow in peripheral tissues but fast in the brain?

  • To prevent transport of nutrients into the brain
  • To achieve therapeutically effective doses in the CNS (correct)
  • To prevent central neurotransmitters from reaching the circulatory system
  • To inhibit the passage of neurotoxic substances across the BBB

Which amino acid analog and precursor crosses the BBB via LAT1 and is then decarboxylated by AADC to dopamine?

<p>L-DOPA (B)</p> Signup and view all the answers

How is transport of molecules across the BBB achieved?

<p>Diffusion as a passive process (A)</p> Signup and view all the answers

Flashcards are hidden until you start studying

More Like This

Use Quizgecko on...
Browser
Browser